Proton Therapy More Efficient and Less Costly in Stage I-II Breast Cancer

Proton Therapy More Efficient and Less Costly in Stage I-II Breast Cancer

shutterstock_149060042Scientists at the University of Texas MD Anderson Proton Therapy Center recently concluded a study that suggests early stage breast cancer patients can benefit from undergoing accelerated partial breast irradiation (APBI) with proton therapy, compared to whole breast irradiation (WBI).

The study evaluated the treatments' advantages in terms of duration and cost, and was presented at the first North America meeting of the Particle Therapy Co-Operative Group (PTCOG) held at the Proton Therapy Center.

According to the American Cancer Society, roughly 232,670 patients will be diagnosed with invasive breast cancer by the end of 2014. Fortunately, in the U.S., breast cancer is usually caught in its early stages (Stage I or II), which greatly increases the likelihood of a 5-year survival rate, and can spare patients from undergoin

Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.